umn pharma inc
(4585:Tokyo Stock Exchange)
Director of R&D, Manager of Clinical Research Development and Director, UMN Pharma Inc.
|Age||Total Calculated Compensation||This person is connected to 6 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Mr. Fumihisa Nakata serves as a Director of R&D and Manager of Clinical Research Development at UMN Pharma Inc. and has been its director since August 2010. Prior to joining UMN Pharma, Mr. Nakata was involved in vaccine development programs as a regulatory member at GlaxoSmithKline K.K. in Japan and succeeded in launching Cervarix (human papilloma virus vaccine) and various influenza vaccines. Previously, he worked in Preclinical and CMC departments at Nissin Flour ...
The Landmark Tower YokohamaPhone: 81 45 263 9200
Yokohama, Kanagawa 220-8126
Fax: 81 45 263 9205
Board Members Memberships*
Director of R&D, Manager of Clinical Research Development and Director
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|